Search results for "Myocardial ischemia"

showing 10 items of 106 documents

Controlled reperfusion after hypothermic heart preservation inhibits mitochondrial permeability transition-pore opening and enhances functional recov…

2006

We investigated whether low-pressure reperfusion may attenuate postischemic contractile dysfunction, limits necrosis and apoptosis after a prolonged hypothermic ischemia, and inhibits mitochondrial permeability transition-pore (MPTP) opening. Isolated rats hearts ( n = 72) were exposed to 8 h of cold ischemia and assigned to the following groups: 1) reperfusion with low pressure (LP = 70 cmH2O) and 2) reperfusion with normal pressure (NP = 100 cmH2O). Cardiac function was assessed during reperfusion using the Langendorff model. Mitochondria were isolated, and the Ca2+resistance capacity (CRC) of the MPTP was determined. Malondialdehyde (MDA) production, caspase-3 activity, and cytochrome c …

MaleNecrosisPhysiologyIschemiaHeart preservationMyocardial IschemiaMyocardial ReperfusionPharmacologyBiologyMitochondrionMitochondrial Membrane Transport ProteinsMitochondria HeartPermeabilityHypothermia InducedPhysiology (medical)MalondialdehydemedicinePressureAnimalsRats WistarCaspase 3Mitochondrial Permeability Transition PoreMyocardiumCytochromes cRecovery of Functionmedicine.diseaseFunctional recoveryRatsMitochondrial permeability transition poreApoptosisAnesthesiaCalciummedicine.symptomCardiology and Cardiovascular MedicineAmerican journal of physiology. Heart and circulatory physiology
researchProduct

Immunohistochemical study on dystrophin expression in CAD-related sudden cardiac death: a marker of early myocardial ischaemia

2018

The aims of this study were to assess if dystrophin can be a tool for the forensic evaluation of sudden cardiac death due to coronary atherosclerotic disease (CAD) and particularly if it can be a marker of early myocardial ischaemia. Then in this investigation, the dystrophin was compared to C5b-9 and fibronectin to analyze if there are some differences in the expression of these proteins. Two groups of CAD-related sudden cardiac death, respectively the group 1 with gross and/or histological evidence and the group 2 with no specific histological signs of myocardial ischaemia were used. A third group formed by cases of acute mechanical asphyxiation was used as a control. The immunohistochemi…

MalePathologymedicine.medical_specialtyForensic pathologyMyocardial InfarctionMyocardial IschemiaMyocardial ischaemia030204 cardiovascular system & hematologyCoronary atherosclerotic diseasePathology and Forensic MedicineSudden cardiac deathDystrophin03 medical and health sciences0302 clinical medicineSettore MED/43 - Medicina LegaleRetrospective StudiemedicineHumans030216 legal & forensic medicineMyocardial infarctionForensic PathologyRetrospective StudiesAgedbiologybusiness.industryRetrospective cohort studyBiomarkerMiddle Agedmedicine.diseaseImmunohistochemistryFibronectinSudden cardiac deathDeath Sudden CardiacItalybiology.proteinImmunohistochemistryFemaleAntibodyDystrophinbusinessBiomarkersHumanInternational Journal of Legal Medicine
researchProduct

Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015

2017

IMPORTANCE Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. OBJECTIVE To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. DESIGN A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted va…

MalePediatricsMyocardial IschemiaNormal DistributionPROGRESSIONBlood Pressure030204 cardiovascular system & hematologyGlobal Health0302 clinical medicineCause of DeathPrevalence030212 general & internal medicineStrokeCause of deathAged 80 and overMortality rateUncertaintyGeneral Medicine11 Medical And Health SciencesMiddle AgedStrokeCARDIOVASCULAR-DISEASEHypertensionCardiologyBlood pressureHipertensióFemaleQuality-Adjusted Life YearsARTERIAL STIFFNESSLife Sciences & BiomedicineIntracranial HemorrhagesMonte Carlo MethodAdultmedicine.medical_specialtySystolePressió sanguíniaRisk Assessment03 medical and health sciencesMedicine General & InternalAGEAge DistributionInternal medicineGeneral & Internal MedicinemedicineDisability-adjusted life yearHumansCORONARY-HEART-DISEASESystoleRenal Insufficiency ChronicSex DistributionMETAANALYSISAgedScience & Technologybusiness.industryMORTALITYKIDNEY-DISEASEmedicine.diseaseHealth SurveysQuality-adjusted life yearBlood pressureArterial stiffnessRISK-FACTORSbusiness
researchProduct

Proteome analysis of myocardial tissue following ischemia and reperfusion--effects of complement inhibition.

2006

Myocardial ischemia-reperfusion injury can be related to complement activation with generation of chemotactic mediators, release of cytokines, leukocyte accumulation, and subsequent severe tissue injury. In this regard, activation of transcription factors (i.e., NFkappaB) and de novo protein synthesis or inflammatory protein degradation seems to play an important role. In the present study, we analyzed the cardiac protein expression following myocardial ischemia (60 min) and reperfusion (180 min) in a rabbit model utilizing two-dimensional electrophoresis and nanoHPLC/ESI-MS/MS for biochemical protein identification. To achieve cardioprotective effects, we used a novel highly selective smal…

MaleProteomeG proteinNeutrophilsMolecular Sequence DataBiophysicsIschemiaMyocardial IschemiaMyocardial Reperfusion InjuryProtein degradationComplement C1 Inactivator ProteinsBiochemistryAnalytical ChemistrySuperoxide dismutaseClassical complement pathwayElectrocardiographyNecrosismedicineProtein biosynthesisAnimalsAmino Acid SequenceMolecular BiologyCreatine KinasebiologySuperoxide DismutaseMyocardiumalpha-Crystallin B ChainComplement System Proteinsmedicine.diseaseMolecular biologyComplement systembiology.proteinCreatine kinaseRabbitsMicrotubule-Associated ProteinsBiomarkersBiochimica et biophysica acta
researchProduct

Heart ischemia and psychosomatics: the role of stressful events and lifestyles

2009

Objective: the aim of our study was to evaluate the role of stressful events, lifestyles and various socio-environmental factors in the beginning of ischemic cardiac diseases, together with cardiovascular factors. Materials and methods: 64 patients with recent cardiac ischemia and 64 controls matched 1:1, according to their sex and age, have been evaluated. The study required the filling in of clinico-anamnestic reports and the evaluation of stressful events, using the Holmes Rahe scale. Results: in the 44% of the patients who had a heart ischemia, an emotional striking event occurred few days before, with a 28% incidence of work and family problems. The mean score of the Holmes Rahe Social…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyHeart diseasestressful eventsMyocardial IschemiaIschemiaheart ischemialcsh:MedicinelifestylesDevelopmental psychologyRisk FactorsInternal medicineAdaptation PsychologicalmedicineHumanspsychosomaticsLife StyleCardiac ischemiaPsychosomaticsIncidence (epidemiology)lcsh:RMiddle Agedmedicine.diseasePsychophysiologic DisordersHolmes and Rahe stress scaleCase-Control StudiesFemaleCardiology and Cardiovascular MedicinePsychologyStress PsychologicalMonaldi Archives for Chest Disease
researchProduct

Relocation of Papillary Muscles for Ischemic Mitral Valve Regurgitation

2014

Objective The assessment of the mitral valve apparatus (MVA) and its modifications during ischemic mitral regurgitation (IMR) is better performed by three-dimensional (3D) transesophageal echocardiography (TEE). The aim of our study was to carry out nonrestrictive mitral annuloplasty in addition to relocation of papillary muscles (PPMs) oriented by preoperative real-time 3D TEE through the mitral valve quantification dedicated software. Methods Since January 2008, a total of 70 patients with severe IMR were examined both before and after mitral valve repair. The mean (SD) coaptation depth and the mean (SD) tenting area were 1.4 (0.4) cm and 3.2 (0.5) cm2, respectively. Intraoperative 3D TEE…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyMitral Valve AnnuloplastyMyocardial ischemiamedicine.medical_treatmentTreatment outcomeMyocardial IschemiaEchocardiography Three-DimensionalThree-dimensional echocardiographyPapillary MuscleIschemic mitral valve regurgitationIntraoperative PeriodRetrospective StudieInternal medicineMitral valveMitral valve annuloplastymedicineHumansRetrospective StudiesAgedMitral valve repairIschemic mitral regurgitationbusiness.industryMitral Valve InsufficiencyGeneral MedicinePapillary Musclesmedicine.diseaseFeasibility StudieTreatment Outcomemedicine.anatomical_structureCardiologyFeasibility StudiesFemaleSurgeryIntraoperative PeriodbusinessMitral valve regurgitationCardiology and Cardiovascular MedicineMitral valve repairEchocardiography TransesophagealHumanInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
researchProduct

Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting

2009

The aim of the study was to evaluate the clinical and echocardiographic outcomes, at rest and under exercise testing, of patients with moderate ischemic mitral regurgitation (IMR) undergoing isolated coronary artery bypass graft surgery (CABG).Between February 2003 and March 2008, 180 patients with moderate IMR who had isolated CABG were enrolled. Patients were matched 1:2 (n = 360) with patients who underwent isolated CABG without IMR (by propensity score). The study endpoints were freedom from all death, cardiac related-death, late events, and cardiac-related events. Late outcomes and left ventricular remodeling were evaluated according to preoperative percent of ejection fraction. Sympto…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtycoronary artery byoass graftingRestmedicine.medical_treatmentMyocardial Ischemiamoderate ischemic mitral regurgitationCoronary Artery DiseaseCoronary artery diseaseInternal medicineMitral valvemedicineHumansMyocardial infarctionCoronary Artery BypassPropensity ScoreVentricular remodelingAgedMitral valve repairMitral regurgitationEjection fractionVentricular Remodelingbusiness.industryMitral Valve InsufficiencyMiddle Agedmedicine.diseaseSurgeryTreatment Outcomemedicine.anatomical_structureEchocardiographyExercise TestCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessArtery
researchProduct

Mortality in patients with acute aortic dissection type A: analysis of pre- and intraoperative risk factors from the German Registry for Acute Aortic…

2015

Acute aortic dissection type A (AADA) is an emergency with excessive mortality if surgery is delayed. Knowledge about independent predictors of mortality on surgically treated AADA patients is scarce. Therefore, this study was conducted to identify pre- and intraoperative risk factors for death.Between July 2006 and June 2010, 2137 surgically treated patients with AADA were enrolled in a multicentre, prospective German Registry for Acute Aortic Dissection type A (GERAADA), presenting perioperative status, operative strategies, postoperative outcomes and AADA-related risk factors for death. Multiple logistic regression analysis was performed to identify the influence of different parameters …

MalePulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentOperative TimeMyocardial IschemiaIschemiaDisease030204 cardiovascular system & hematologyBrain Ischemia03 medical and health sciences0302 clinical medicineIschemiaRisk FactorsGermanymedicine.arteryHumansMedicineProspective StudiesRegistriesCardiopulmonary resuscitationIntraoperative ComplicationsAortic dissectionLegAortaAortic Aneurysm Thoracicbusiness.industryGeneral MedicineOdds ratioPerioperativeMiddle Agedmedicine.diseaseSurgeryAortic DissectionTreatment OutcomeHemiparesis030228 respiratory systemAcute DiseaseFemaleSurgerymedicine.symptomCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalEuropean Journal of Cardio-Thoracic Surgery
researchProduct

Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry.

2019

Introduction and objectives: There is current controversy regarding the benefits of percutaneous recanalization (PCI) of chronic total coronary occlusions (CTO). Our aim was to determine acute and follow-up outcomes in our setting. Methods: Two-year prospective registry of consecutive patients undergoing PCI of CTO in 24 centers. Results: A total of 1000 PCIs of CTO were performed in 952 patients. Most were symptomatic (81.5%), with chronic ischemic heart disease (59.2%). Previous recanalization attempts had been made in 15%. The mean SYNTAX score was 19.5 +/- 10.6 and J-score was > 2 in 17.3%. A retrograde procedure was performed in 92 patients (9.2%). The success rate was 74.9% and was hi…

MaleReoperationmedicine.medical_specialtyPercutaneousmedicine.medical_treatmentPerforation (oil well)Myocardial Ischemia030204 cardiovascular system & hematology03 medical and health sciencesPercutaneous Coronary InterventionPostoperative Complications0302 clinical medicineInternal medicineMyocardial RevascularizationmedicineHumansProspective StudiesRegistriesMyocardial infarctionProspective cohort studyUltrasonography InterventionalAgedPortugalbusiness.industryMortality ratePercutaneous coronary interventionGeneral Medicinemedicine.diseaseTreatment OutcomeCoronary OcclusionSurgery Computer-AssistedSpainCoronary occlusionChronic DiseaseConventional PCICardiologyFemaleCTO Cardiopatía isquémica crónica Chronic ischemic cardiomyopathy Chronic total occlusions IVUS OCT Oclusiones crónicasbusiness
researchProduct

Statins, Fracture Risk, and Bone Remodeling: What Is True?

2006

Besides the action on plasma lipid levels, statins show a series of ancillary effects defined as all of their vascular and nonvascular effects independent from the cholesterol reduction. It has been recently hypothesized that one of these ancillary effects could be the improvement of bone health, due to the interference with bone metabolism. This may potentially represent the rationale for statins' use in the treatment of osteoporosis, the most common disease of the bone. Both experimental observations and clinical studies on this topic generated a number of conflicting results; however, the largest randomized clinical trials, the Scandinavian Simvastatin Survival Study (4S), Long Term Inte…

MaleRiskSimvastatinmedicine.medical_specialtyOsteoporosisMyocardial IschemiaBioinformaticsBone remodelinglaw.inventionFractures Bonechemistry.chemical_compoundRandomized controlled trialRisk FactorslawHumansMedicineLongitudinal StudiesRisk factorPravastatinRandomized Controlled Trials as Topicbusiness.industryCholesterolOsteoporosiStatinnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseSurgerychemistrySimvastatinOsteoporosisFemalelipids (amino acids peptides and proteins)Bone RemodelingTherapyHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessFracturesHeart Protection StudyPravastatinmedicine.drugThe American Journal of the Medical Sciences
researchProduct